Sigyn Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONVERTIBLE NOTE PAYABLE (Details Narrative)

CONVERTIBLE NOTE PAYABLE (Details Narrative) - USD ($)			1 Months Ended		11 Months Ended	12 Months Ended
CONVERTIBLE NOTE PAYABLE (Details Narrative) - USD ($)	May 30, 2017	Dec. 21, 2015	Dec. 31, 2016	Nov. 30, 2016	Nov. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Nov. 10, 2016	Jun. 30, 2016	Nov. 30, 2015
Successor [Member]
Interest expense			$ 65,146
Derivative liabilities			$ 153,663			$ 153,663
Successor [Member] \| December 2015 Purchaser Conversion [Member]
Description of terms of conversion feature			December 2015 Purchaser Conversion Price of $0.12, subject to potential future adjustments described below. If the total outstanding balance of the Note were convertible as of December 31, 2016, the December 2015 Note would have been convertible into 7,187,500 shares of our common stock.
Successor [Member] \| November 2016 Notes [Member]
Unamortized debt discount			$ 256,722			256,722
Interest expense			16,078
Successor [Member] \| November 2015 Notes [Member]
Unamortized debt discount			273,859			273,859
Interest expense			48,791
Successor [Member] \| December 2015 Optional Redemption [Member]
Derivative liabilities			97,348	$ 130,448	$ 130,448	97,348
Re-measurement of derivative liability			36,247
Contingent fair value			$ 199,150			$ 199,150
Successor [Member] \| Warrant [Member]
Share price (in dollars per share)			$ 0.11			$ 0.11	$ 0.25	$ 0.12
Successor [Member] \| Warrant [Member] \| November 2016 Notes [Member]
Unamortized debt discount			$ 283,172			$ 283,172
Number of common shares issued						100,002
Warrants granted						$ 108,567
Successor [Member] \| Warrant [Member] \| November 2015 Notes [Member]
Unamortized debt discount							$ 862,500
Number of common shares issued							625,000
Warrants granted							$ 439,107
Debt origination expenses							$ 429,000
Successor [Member] \| November 2016 Purchaser Conversion Shares [Member]
Conversion rate			$ 0.12			$ 0.12
Embedded derivative liability			$ 32,016			$ 32,016
Accretion of debt discount			2,395,850
Derivative liabilities			23,995			$ 23,995
Re-measurement of derivative liability			$ 8,021
Successor [Member] \| November 2016 Purchaser Warrants [Member]
Conversion rate			$ 0.12			$ 0.12
Embedded derivative liability			$ 108,597			$ 108,597
Trading days			5 years
Issuance date			6 months
Share price (in dollars per share)			$ 0.30			$ 0.30
Derivative liabilities			$ 105,338			$ 105,338
Re-measurement of derivative liability			3,259
Successor [Member] \| November 2016 Purchaser Common Stock [Member]
Embedded derivative liability			$ 240,615			$ 240,615
Value of shares issued				$ 833,354
Number of shares issued			244,945	100,002
Successor [Member] \| November 2015 Purchaser Conversion Shares [Member]
Conversion rate							$ 0.12
Accretion of debt discount							$ 7,187,500
Derivative liabilities							32,320
Re-measurement of derivative liability			$ 27,210
Derivative fair value							$ 88,983			$ 59,530
Successor [Member] \| November 2015 Purchaser Warrants [Member]
Conversion rate			$ 0.12			$ 0.12
Trading days						5 years
Issuance date						6 months
Derivative liabilities						$ 353
Share price (in dollars per share)			$ 0.30			$ 0.30
Derivative liabilities			$ 367,958			$ 367,958
Re-measurement of derivative liability			4,840
Derivative fair value			$ 439,107	$ 368,311	368,311	439,107
Successor [Member] \| Securities Purchase Agreement [Member]
Issuance date			Nov. 10, 2016				Dec. 23, 2015
Description of terms of conversion feature			(ii) a November 2016 Note with a principal amount of $1.00 for each $0.86956 for each $1.00 paid by each purchaser for such purchaser’s November 2016 Note; and (iii) November 2016 Warrants to purchase up to a number of shares of Common Stock equal to 100% of such purchaser’s November 2016 Note principal amount divided by $0.12 (“Purchaser Conversion Price”), the conversion price in effect on the Initial Closing Date, with a per share exercise price equal to $0.30, subject to adjustment.				(ii) a Note with a principal amount of $1.00 for each $0.86956 for each $1.00 paid by each purchaser for such purchasers Note; and (iii) Warrants to purchase up to a number of shares of Common Stock equal to 100% of such purchasers Note principal amount divided by $0.12 (Purchaser Conversion Price), the conversion price in effect on the Initial Closing Date, with a per share exercise price equal to $0.30, subject to adjustment.
Issuance of convertible debt			$ 244,945				$ 724,500
Unamortized debt discount			$ 42,557			$ 42,557	$ 138,000
Maturity date			May 10, 2018				Jun. 23, 2017
Interest rate			15.00%			15.00%	15.00%
Conversion rate			$ 0.12			$ 0.12	$ 0.12
Percentage of beneficially own in excess of common shares outstanding			9.99%			9.99%	9.99%
Percentage of right to participate subsequent financing			100.00%			100.00%	100.00%
Description of redemption of debt intrument							The Notes provide that commencing six (6) months after the Original Issue Date, we will have the option of prepaying the outstanding principal amount of the Notes (an Optional Redemption), in whole or in part, by paying to the holders a sum of money in cash equal to one hundred percent (100%) of the principal amount to be redeemed, together with accrued but unpaid interest thereon, if any, and any and all other sums due, accrued or payable to the holder arising under the Note through the Redemption Payment Date and 2.8986 shares of our Common Stock for each $1.00 of Note principal amount being redeemed. A Notice of Redemption, if given, may be given on the first Trading Day following twenty (20) consecutive Trading Days during which all of the Equity Conditions, as defined, have been in effect.
Embedded derivative liability							$ 88,983
Share price (in dollars per share)			$ 0.11			$ 0.11			$ 0.25
Successor [Member] \| Securities Purchase Agreement [Member] \| Common Stock [Member]
Common stock convertible shares			2,500,000
Unamortized debt discount			$ 273,859			$ 273,859
Common stock convertible amount			625,000
Accretion of debt discount			$ 48,791
Successor [Member] \| Securities Purchase Agreement [Member] \| Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member]
Conversion rate			$ 0.3			$ 0.3
Percentage of right to participate subsequent financing			100.00%			100.00%
Trading days			5 years
Issuance date			6 months
Successor [Member] \| Securities Purchase Agreement [Member] \| Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member] \| Secured Convertible Notes [Member]
Principle amount			$ 287,502			$ 287,502	$ 862,500
Successor [Member] \| Securities Purchase Agreement [Member] \| Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member] \| Common Stock [Member]
Common stock convertible shares			833,354				2,500,000
Successor [Member] \| Securities Purchase Agreement [Member] \| Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member] \| Warrant [Member]
Common stock convertible shares			2,395,850				7,187,542
Description of terms of conversion feature							ii) a December 2015 Note with a principal amount of $1.00 for each $0.86956 for each $1.00 paid by each purchaser for such purchaser’s December 2015 Note; and (iii) December 2015 Warrants to purchase up to a number of shares of Common Stock equal to 100% of such purchaser’s December 2015 Note principal amount divided by $0.12 (“December 2015 Purchaser Conversion Price”), the conversion price in effect on the Initial Closing Date, with a per share exercise price equal to $0.30, subject to adjustment.
Successor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Conversion rate	$ 0.08
Successor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Common Stock [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Share price (in dollars per share)	0.08
Successor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Warrant [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Share price (in dollars per share)	$ 0.30
Warrant exercisable term	5 years
Predecessor [Member]
Unamortized debt discount				$ 31,500	31,500		$ 29,039
Interest expense					$ 130,499		52,772
Accretion of debt discount							29,039
Value of shares issued							200,000
Number of shares issued		8,800,000
Derivative liabilities
Predecessor [Member] \| Common Stock [Member]
Value of shares issued
Predecessor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Conversion rate	$ 0.08
Predecessor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Common Stock [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Share price (in dollars per share)	0.08
Predecessor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Warrant [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Share price (in dollars per share)	$ 0.30
Warrant exercisable term	5 years